Organo Corp
TSE:6368

Watchlist Manager
Organo Corp Logo
Organo Corp
TSE:6368
Watchlist
Price: 8 130 JPY 0.12% Market Closed
Market Cap: 376.9B JPY
Have any thoughts about
Organo Corp?
Write Note
Section:
 

Relative Value

The Relative Value of one Organo Corp stock under the Base Case scenario is 5 776.02 JPY. Compared to the current market price of 8 130 JPY, Organo Corp is Overvalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
5 776.02 JPY
Overvaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.3
P/S
P/S
Price to Sales
2.3
vs History
3
vs Industry
32
Median 3Y
1.3
Median 5Y
0.9
Industry
1.6
Forward
2.3
More Details
18.8
P/E
P/E
Price to Earnings
18.8
vs History
6
vs Industry
37
Median 3Y
14.5
Median 5Y
10.6
Industry
20.7
Forward
20
More Details
22.9
P/OCF
P/OCF
Price to OCF
22.9
vs History
19
vs Industry
5
Median 3Y
9.2
Median 5Y
4.4
Industry
14.8
More Details
76.4
P/FCFE
P/FCFE
Price to FCFE
76.4
vs History
6
vs Industry
10
Median 3Y
20
Median 5Y
16.5
Industry
21.3
More Details
3.5
P/B
P/B
Price to Book Value
3.5
vs History
4
vs Industry
20
Median 3Y
2
Median 5Y
1.3
Industry
1.8
More Details
2.3
EV/S
EV/S
Enterprise Value to Sales
2.3
vs History
3
vs Industry
33
Median 3Y
1.3
Median 5Y
0.8
Industry
1.7
Forward
2.2
More Details
7.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.4
vs History
7
vs Industry
37
Median 3Y
4.9
Median 5Y
3.2
Industry
6.2
More Details
12.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.8
vs History
9
vs Industry
36
Median 3Y
10
Median 5Y
7.5
Industry
12.4
Forward
12.5
More Details
13.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
13.7
vs History
9
vs Industry
40
Median 3Y
11.1
Median 5Y
8.3
Industry
16
More Details
22
EV/OCF
EV/OCF
Enterprise Value to OCF
22
vs History
19
vs Industry
5
Median 3Y
8.6
Median 5Y
2.4
Industry
14.8
More Details
25
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
25
vs History
19
vs Industry
3
Median 3Y
11.5
Median 5Y
3.3
Industry
18.1
More Details
2.6
EV/IC
EV/IC
Enterprise Value to IC
2.6
vs History
1
vs Industry
23
Median 3Y
1.4
Median 5Y
1
Industry
1.4
More Details

Multiples Across Competitors

Competitors Multiples
Organo Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Organo Corp
TSE:6368
374B JPY 2.3 18.8 12.8 13.7
US
Parker-Hannifin Corp
NYSE:PH
83.1B USD 4.2 28.7 18.1 22.2
US
Illinois Tool Works Inc
NYSE:ITW
76.5B USD 4.8 22.1 17.8 19.5
SE
Atlas Copco AB
STO:ATCO A
822.1B SEK 4.7 28.6 18.3 22.5
JP
Mitsubishi Heavy Industries Ltd
TSE:7011
7.5T JPY 1.5 31.6 14.7 21.5
US
Otis Worldwide Corp
NYSE:OTIS
37.3B USD 2.6 22.9 18.9 20.6
US
Ingersoll Rand Inc
NYSE:IR
37B USD 5.2 44.2 21.3 28.4
CH
Schindler Holding AG
SIX:SCHP
26.8B CHF 2.4 44 19.4 26.8
US
Xylem Inc
NYSE:XYL
28.6B USD 3.4 34.4 17.2 25.5
US
Dover Corp
NYSE:DOV
25.9B USD 3.1 16.6 16.6 20.5
US
Fortive Corp
NYSE:FTV
25.8B USD 4.2 29 16.7 24.2
P/E Multiple
Earnings Growth P/E to Growth
JP
Organo Corp
TSE:6368
Average P/E: 29.2
18.8
32%
0.6
US
Parker-Hannifin Corp
NYSE:PH
28.7
50%
0.6
US
Illinois Tool Works Inc
NYSE:ITW
22.1
16%
1.3
SE
Atlas Copco AB
STO:ATCO A
28.6
23%
1.3
JP
Mitsubishi Heavy Industries Ltd
TSE:7011
31.6
63%
0.5
US
Otis Worldwide Corp
NYSE:OTIS
22.9
31%
0.7
US
Ingersoll Rand Inc
NYSE:IR
44.2
108%
0.4
CH
Schindler Holding AG
SIX:SCHP
44
75%
0.6
US
Xylem Inc
NYSE:XYL
34.4
113%
0.3
US
Dover Corp
NYSE:DOV
16.6
35%
0.5
US
Fortive Corp
NYSE:FTV
29
84%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Organo Corp
TSE:6368
Average EV/EBITDA: 17.4
12.8
41%
0.3
US
Parker-Hannifin Corp
NYSE:PH
18.1
28%
0.7
US
Illinois Tool Works Inc
NYSE:ITW
17.8
15%
1.2
SE
Atlas Copco AB
STO:ATCO A
18.3
16%
1.1
JP
Mitsubishi Heavy Industries Ltd
TSE:7011
14.7
64%
0.2
US
Otis Worldwide Corp
NYSE:OTIS
18.9
21%
0.9
US
Ingersoll Rand Inc
NYSE:IR
21.3
43%
0.5
CH
Schindler Holding AG
SIX:SCHP
19.4
43%
0.5
US
Xylem Inc
NYSE:XYL
17.2
74%
0.2
US
Dover Corp
NYSE:DOV
16.6
16%
1
US
Fortive Corp
NYSE:FTV
16.7
30%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Organo Corp
TSE:6368
Average EV/EBIT: 22.3
13.7
N/A N/A
US
Parker-Hannifin Corp
NYSE:PH
22.2
36%
0.6
US
Illinois Tool Works Inc
NYSE:ITW
19.5
15%
1.3
SE
Atlas Copco AB
STO:ATCO A
22.5
18%
1.3
JP
Mitsubishi Heavy Industries Ltd
TSE:7011
21.5
N/A N/A
US
Otis Worldwide Corp
NYSE:OTIS
20.6
21%
1
US
Ingersoll Rand Inc
NYSE:IR
28.4
72%
0.4
CH
Schindler Holding AG
SIX:SCHP
26.8
62%
0.4
US
Xylem Inc
NYSE:XYL
25.5
108%
0.2
US
Dover Corp
NYSE:DOV
20.5
22%
0.9
US
Fortive Corp
NYSE:FTV
24.2
46%
0.5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.